Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | SZU-MIN HSIEH ; Liu, Ming-Che; Chen, Yen-Hsu; Lee, Wen-Sen; Hwang, Shinn-Jang; Cheng, Shu-Hsing; Ko, Wen-Chien; Hwang, Kao-Pin; Wang, Ning-Chi; Lee, Yu-Lin; Lin, Yi-Ling; Shih, Shin-Ru; Huang, Chung-Guei; Liao, Chun-Che; Liang, Jian-Jong; Chang, Chih-Shin; Chen, Charles; Lien, Chia En; Tai, I-Chen; Lin, Tzou-Yien | The Lancet. Respiratory medicine | 87 | 81 | |
2023 | Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study | Lien, Chia En; Liu, Ming-Che; Wang, Ning-Chi; Liu, Luke Tzu-Chi; Wu, Chung-Chin; Tang, Wei-Hsuan; Lian, Wei-Cheng; Kuan-Ying A. Huang ; Chen, Charles | Vaccines | |||
2014 | 奇異變形桿菌中rpoE基因功能之研究 | 劉明哲; Liu, Ming-Che |